Anemia in inflammatory bowel disease
prevalence, differential diagnosis and association with clinical and laboratory variables
Keywords:
Anemia, Inflammatory bowel diseases, Prevalence, Association, Diagnosis, differentialAbstract
CONTEXT AND OBJECTIVES: Anemia is the most frequent extraintestinal complication of inflammatory bowel disease. This study aimed to: 1) determine the prevalence of anemia among patients with inflammatory bowel disease; 2) investigate whether routine laboratory markers are useful for diagnosing anemia; and 3) evaluate whether any association exists between anemia and clinical/laboratory variables. DESIGN AND SETTING: Cross-sectional at a federal university. METHODS: 44 outpatients with Crohn’s disease and 55 with ulcerative colitis were evaluated. Clinical variables (disease activity index, location of disease and pharmacological treatment) and laboratory variables (blood count, iron laboratory, vitamin B12 and folic acid) were investigated. RESULTS: Anemia and/or iron laboratory disorders were present in 75% of the patients with Crohn’s disease and in 78.2% with ulcerative colitis. Anemia was observed in 20.5% of the patients with Crohn’s disease and in 23.6% with ulcerative colitis. Iron-deficiency anemia was highly prevalent in patients with Crohn’s disease (69.6%) and ulcerative colitis (76.7%). Anemia of chronic disease in combination with iron deficiency anemia was present in 3% of the patients with Crohn’s disease and in 7% of the patients with ulcerative colitis. There was no association between anemia and disease location. In ulcerative colitis, anemia was associated with the disease activity index. CONCLUSIONS: Most patients present iron laboratory disorders, with or without anemia, mainly due to iron deficiency. The differential diagnosis between the two most prevalent types of anemia was made based on clinical data and routine laboratory tests. In ulcerative colitis, anemia was associated with the disease activity index.
Downloads
References
Kornbluth A, Sachar DB, Salomon P. Crohn’s disease. In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease, 6th ed. Philadelphia: Saunders; 1998. p. 1708-34.
Miszputen SJ, Cutait R. Doenças inflamatórias intestinais. In: Prado FC, Ramos J, Ribeiro do Valle J, editors. Atualização terapêutica, 23rd ed. São Paulo: Artes Médicas; 2007. p. 399-405.
Jewell DP. Ulcerative colitis In: Feldman M, Scharschmidt BF, Sleisenger MH, editors. Gastrointestinal and liver disease. 6th ed. Philadelphia: Saunders; 1998. p. 1735-61.
Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 2001;96(8):2296-8.
Gasché C, Reinisch W, Lochs H, et al. Anemia in Crohn’s disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci. 1994;39(9):1930-4.
Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med. 1996;334(10):619-23.
Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24(11-12):1507-23.
Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther. 2001;15(4):429-38.
Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol. 2001;96(8):2382-7.
Weiss G. Iron and anemia of chronic disease. Kidney Int Suppl. 1999;69:S12-7.
Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica. 2010;95(2):199-205.
Spivak JL. The blood in systemic disorders. Lancet. 2000;355(9216):1707-12.
Means RT. Hepcidin and cytokines in anaemia. Hematology. 2004;9(5-6):357-62.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-23.
Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010;95(2):175-8.
Sandborn W. Erythropoietin for inflammatory bowel disease anemia. Gastroenterology. 1997;112(2):660-1.
Gasché C, Dejaco C, Waldhoer T, et al. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med. 1997;126(10):782-7.
Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12(2):123-30.
Gasche C, Dejaco C, Reinisch W, et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion. 1999;60(3):262-7.
Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190-7.
Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15(37):4659-65.
Teixeira GJT, Silva JH, Teixeira MG, et al. Manifestações extra-intestinais após tratamento cirúrgico da retocolite ulcerativa [Extra-intestinal manifestations after ulcerative colitis surgical treatment]. Rev Bras Colo-proctol. 2001;21(1):9-18.
Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;1(8167):514.
Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041-8.
Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53.
Massey AC. Microcytic anemia. Differencial diagnosis and management of iron deficiency anemia. Med Clin North Am. 1992;76(3):549-66.
Turati C, Tursini P, Franzini C, et al. Saturazione della transferrina del siero e sovraccarico di ferro. Biochim Clin. 1997;21:10-5.
Weatherall DJ, Clegg JB. The thalassaemia syndromes. 3rd ed. Oxford: Blackwell Scientific Publications; 1981.
Marengo-Rowe AJ. Rapid electrophoresis and quantitation of haemoglobins on cellulose acetate. J Clin Path. 1965;18(6):790-2.
Pembrey ME, MacWade P, Weatherall DJ. Reliable routine estimation of small amounts of foetal haemoglobin by alkali denaturation. J Clin Pathol. 1972;25(8):738-40.
World Health Organization. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva: World Health Organization; 2001. Available from: http://whqlibdoc.who.int/hq/2001/who_NHD_01.3.pdf. Accessed in 2013 (May 23).
Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(12):1545-53.
Arthur CK, Isbister JP. Iron deficiency. Misunderstood, misdiagnosed and mistreated. Drugs. 1987;33(2):171-82.
Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116 Suppl 7A:44S-49S.
Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow- up study. World J Gastroenterol. 2003;9(10):2300-7.
Ahluwalia N, Lammi-Keefe CJ, Bendel RB, et al. Iron deficiency and anemia of chronic disease in elderly women: a discriminant-analysis for differentiation. Am J Clin Nutr. 1995;61(3):590-6.
